Intratympanic Injections

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intratympanic Injections trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05851508

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks…

Ménière's disease is an inner ear disorder in which patients suffer from attacks of vertigo, tinnitus and hearing loss. To date, it is unclear what the best tre…

Netherlands148 participantsStarted 2023-10-01

Treatment: Methylprednisolon, Placebo

All recent trials (34 shown)

Not Yet RecruitingPhase 1/2

NCT06437054

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing…

Location not specified26 participantsStarted 2026-12-15

Treatment: Dexamethasone, Hyaluronic acid

Not Yet RecruitingPhase 1/2

NCT07404709

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Ste…

The goal of this clinical trial is to learn if small extracellular vesicles derived from mesenchymal stem cells work to treat severe and above sudden sensorineu…

China9 participantsStarted 2026-02-28

Treatment: Tympanic injection of hUC-MSC-sEV-003 (small extracellular vesicles) at low doses, Tympanic injection of hUC-MSC-sEV-003 (small extracellular vesicles) at moderate doses

Intratympanic Injections

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks…

All recent trials (34 shown)

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Ste…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks…

All recent trials (34 shown)

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Ste…

Use of Vibration Anesthesia Device in Intratympanic Injections

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

Intratympanic Steroid for Bell's Palsy

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

FX-322 in Adults With Stable Sensorineural Hearing Loss

FX-322 in Adults With Acquired Sensorineural Hearing Loss

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

OTO-313 in Subjects With Unilateral Subjective Tinnitus

OTO-313 in Subjects With Subjective Tinnitus

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease